Bogart Wealth LLC’s China Pharma Holdings CPHI Stock Holding History

Bogart Wealth LLC’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	–	–	349
2018 Q3	$0	Hold	2	–	–	﹤0.01%	332
2018 Q2	$0	Buy	+2	New	+$270	﹤0.01%	350

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

AIC

Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return

Bogart Wealth LLC's CPHI Position: Q4 2018 in Review

Bogart Wealth LLC sold out of China Pharma Holdings (CPHI) in Q4 2018, closing a stake of 2 shares.

Bogart Wealth LLC first reported a position in CPHI in Q2 2018 and held it in 2 quarters. The position peaked at $0 in Q3 2018. 9 funds tracked by Wall St. Rank hold CPHI as of Q4 2018.

Bogart Wealth LLC reported no remaining China Pharma Holdings position as of Q4 2018 after selling out during the quarter.
Bogart Wealth LLC sold 2 China Pharma Holdings shares in Q4 2018.
Bogart Wealth LLC first reported a position in China Pharma Holdings in Q2 2018 and held it in 2 quarters.
Bogart Wealth LLC's China Pharma Holdings position peaked at $0 in Q3 2018.
9 funds tracked by Wall St. Rank held China Pharma Holdings as of Q4 2018.

Based on Bogart Wealth LLC's 13F filing for Q4 2018, filed 15 Jan 2019.